• OPEN AN ACCOUNT
Indian Indices
Sensex
77,235.46 -492.70
( -0.63%)
Global Indices
Nasdaq
53,489.46 -263.95
(-0.49%)
Dow Jones
7,767.06 -39.70
(-0.51%)
Hang Seng
67,388.40 -1,831.85
(-2.65%)
Nikkei 225
10,727.81 -22.30
(-0.21%)
Forex
USD-INR
95.53 0.14
(0.14%)
EUR-INR
110.53 0.55
(0.50%)
GBP-INR
129.27 0.59
(0.46%)
JPY-INR
0.60 0.00
(0.19%)

EQUITY - MARKET SCREENER

BDH Industries Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524828
INE278D01018
131.4161458
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
29.03
313.86
EPS(TTM)
Face Value()
Div & Yield %
18.77
10
0.92
 

city pulse multiventures ltd
Natco Pharma consolidated net profit declines 34.11% in the March 2026 quarter
May 30,2026
Net profit of Natco Pharma declined 34.11% to Rs 267.90 crore in the quarter ended March 2026 as against Rs 406.60 crore during the previous quarter ended March 2025. Sales declined 39.47% to Rs 739.10 crore in the quarter ended March 2026 as against Rs 1221.00 crore during the previous quarter ended March 2025.

For the full year,net profit declined 24.76% to Rs 1418.50 crore in the year ended March 2026 as against Rs 1885.40 crore during the previous year ended March 2025. Sales declined 7.93% to Rs 4078.30 crore in the year ended March 2026 as against Rs 4429.50 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales739.101221.00 -39 4078.304429.50 -8
OPM %17.2644.89 -35.2249.58 -
PBDT194.50604.20 -68 1697.402526.60 -33
PBT144.10505.90 -72 1490.802291.40 -35
NP267.90406.60 -34 1418.501885.40 -25